Neonatal GALT
A precise fluorometric assay for the quantitative in vitro determination of galactose-1-phosphate uridyltransferase (GALT) activity in dried blood samples. The Neonatal GALT test is designed for the early detection of classic...

Overview
Accurate enzyme-based screening for early detection of galactosemia. Hereditary galactosemia is a severe disorder of carbohydrate metabolism caused by GALT enzyme deficiency. Without early diagnosis and management, affected newborns can develop liver failure, cataracts, or neurological impairment. The Neonatal GALT test provides a quantitative fluorometric analysis of enzyme activity from dried blood spots, ensuring reliable detection of GALT deficiency. When identified early, simple dietary adjustments—eliminating lactose and galactose—can prevent long-term complications and enable normal development.

Key Features
- Designed for efficient newborn screening of classic galactosemia
- Quantitative and reproducible enzyme activity results
- Assay time of only 30 minutes
- High stability and reliability across test runs
- Simplified workflow for high-throughput laboratories
Technical Specifications
- Format : 10 solid plates (96 wells each)
- Total Wells : 960
- Catalogue Number : 6199810
IS Modules
- Quantitative fluorometric determination of GALT activity
- Automated plate-to-plate transfer procedure minimizes disc floating interference
- No false positives due to G6PD deficiency
- Compatible with both manual and automated proceduress
- Reduced processing time of 2 hours 30 minutes
